Merck Sharp & Dohme LLC recalls Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufacture
Recalled December 31, 2025 · FDA recall D-0242-2026 · Merck Sharp & Dohme
Hazard
Presence of particulate matter: potential presence of metal particulates in the product. · FDA Class II
Units
845 kits
Sold at
Nationwide in the USA
Description
Presence of particulate matter: potential presence of metal particulates in the product.
Product
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Manufacturer(s)
Merck Sharp & Dohme LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →